Wei Wang

21.7k total citations · 2 hit papers
440 papers, 9.9k citations indexed

About

Wei Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Wei Wang has authored 440 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 218 papers in Pulmonary and Respiratory Medicine, 121 papers in Oncology and 93 papers in Surgery. Recurrent topics in Wei Wang's work include Lung Cancer Diagnosis and Treatment (70 papers), Lung Cancer Treatments and Mutations (69 papers) and Cancer Immunotherapy and Biomarkers (46 papers). Wei Wang is often cited by papers focused on Lung Cancer Diagnosis and Treatment (70 papers), Lung Cancer Treatments and Mutations (69 papers) and Cancer Immunotherapy and Biomarkers (46 papers). Wei Wang collaborates with scholars based in China, United States and United Kingdom. Wei Wang's co-authors include Jianxing He, Wenhua Liang, Hengrui Liang, Wei‐jie Guan, Caichen Li, Jianfu Li, Shiyue Li, Ke Xu, Weixiang Lu and Ruchong Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.

In The Last Decade

Wei Wang

386 papers receiving 9.8k citations

Hit Papers

Cancer patients in SARS-CoV-2 infection: a nationwide ana... 2020 2026 2022 2024 2020 2020 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
    2020 2.9k citations Wenhua Liang, Wei Wang et al. profile →
  2. Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
    2020 616 citations Wei Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Wang China 43 4.2k 2.8k 2.2k 2.0k 1.5k 440 9.9k
Wenhua Liang China 41 5.1k 1.2× 3.4k 1.2× 1.0k 0.5× 2.2k 1.1× 890 0.6× 282 9.7k
Justin Stebbing United Kingdom 67 6.1k 1.5× 2.1k 0.7× 4.3k 1.9× 1.6k 0.8× 3.5k 2.4× 524 14.8k
Lei Chen China 54 4.5k 1.1× 2.7k 1.0× 3.4k 1.5× 762 0.4× 2.0k 1.4× 606 13.2k
Charles S. Dela Cruz United States 41 1.5k 0.4× 2.5k 0.9× 3.7k 1.6× 1.5k 0.7× 1.2k 0.8× 158 9.9k
Peter C. Adamson United States 59 2.7k 0.7× 2.2k 0.8× 3.5k 1.6× 689 0.3× 982 0.7× 238 11.3k
Mieke Van Hemelrijck United Kingdom 47 2.3k 0.5× 2.4k 0.9× 1.3k 0.6× 474 0.2× 1.4k 0.9× 364 7.8k
Paolo Bruzzi Italy 67 5.1k 1.2× 1.7k 0.6× 2.0k 0.9× 434 0.2× 2.5k 1.7× 325 14.3k
Wei Zhang China 50 1.8k 0.4× 918 0.3× 4.2k 1.9× 1.0k 0.5× 1.9k 1.3× 373 10.4k
Diego Serraino Italy 57 5.7k 1.4× 2.2k 0.8× 1.3k 0.6× 971 0.5× 1.2k 0.8× 379 12.6k
Gang Xu China 39 1.5k 0.4× 940 0.3× 2.0k 0.9× 2.2k 1.1× 552 0.4× 218 8.0k

Countries citing papers authored by Wei Wang

Since Specialization
Citations

This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).

Fields of papers citing papers by Wei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.

Co-authorship network of co-authors of Wei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wang. A scholar is included among the top collaborators of Wei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wang. Wei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Fei, Weili Li, Wei Yan, et al.. (2025). Anthracycline-induced cardiotoxicity: emerging mechanisms and therapies. 2(1). 100074–100074. 1 indexed citations
2.
Zhang, Mingzi, Wei Wang, Yijun Xia, et al.. (2025). Management of Complex Anal Fistula in Recurrent Perianal Abscess: A Case Report. American Journal of Case Reports. 26. e948682–e948682.
3.
Ge, Fangfei, et al.. (2025). Hydrogel-Based Therapeutic Strategies for Periodontal Tissue Regeneration: Advances, Challenges, and Future Perspectives. Pharmaceutics. 17(11). 1382–1382. 1 indexed citations
4.
Kang, Xi, Shilin Wu, Zhen Wang, et al.. (2025). Can GRPO Boost Complex Multimodal Table Understanding?. 12642–12655.
5.
Jiang, Chunqi, et al.. (2025). The curvilinear relationship between Framingham Steatosis Index and depression: insights from a nationwide study. Frontiers in Psychiatry. 15. 1510327–1510327.
6.
7.
Tang, Yihong, Kehai Chen, Xuefeng Bai, et al.. (2025). The Rise of Darkness: Safety-Utility Trade-Offs in Role-Playing Dialogue Agents. 16313–16337. 1 indexed citations
8.
9.
Pan, Wei, et al.. (2024). Open-set recognition based on the combination of deep learning and hypothesis testing for detecting unknown nuclear faults. Nuclear Engineering and Design. 429. 113654–113654.
10.
Peng, Yun, et al.. (2024). Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis. Therapeutic Advances in Respiratory Disease. 18. 2683804651–2683804651. 2 indexed citations
11.
12.
Li, Weili, Yuqin Zhang, Wei Yan, et al.. (2024). New insights into mitochondrial quality control in anthracycline-induced cardiotoxicity: molecular mechanisms, therapeutic targets, and natural products. International Journal of Biological Sciences. 21(2). 507–523. 2 indexed citations
13.
14.
Zeng, Yuan, Jun Liu, Minghui Wan, et al.. (2023). The association of postoperative radiotherapy with survival in resected N2 non-small cell lung cancer. Journal of Thoracic Disease. 15(1). 42–53. 2 indexed citations
15.
Gao, Xiaoshuai, Xi Jin, Wei Wang, et al.. (2023). β-Adrenoceptors regulate urothelial inflammation and zonula occludens in the bladder outlet obstruction model. International Immunopharmacology. 127. 111371–111371. 1 indexed citations
16.
Peng, Yun, Bing Dai, Hongwen Zhao, et al.. (2022). Comparison between high-flow nasal cannula and noninvasive ventilation in COVID-19 patients: a systematic review and meta-analysis. Therapeutic Advances in Respiratory Disease. 16. 2673692991–2673692991. 8 indexed citations
17.
Yin, Haisen, Jianwei Zhang, Hanping Zhang, et al.. (2022). Fusobacterium nucleatum promotes proliferation in oesophageal squamous cell carcinoma via AHR / CYP1A1 signalling. FEBS Journal. 290(3). 837–854. 14 indexed citations
18.
Dai, Bing, et al.. (2022). Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis. Therapeutic Advances in Respiratory Disease. 16. 2673671259–2673671259. 9 indexed citations
19.
Dai, Lili, et al.. (2022). Effect of Gefitinib Combined with Chemotherapy in Patients with Advanced NSCLC: A Retrospective Cohort Study. SHILAP Revista de lepidopterología. 3 indexed citations
20.
Singer, Josef, Judit Fazekas, Wei Wang, et al.. (2014). Generation of a Canine Anti-EGFR (ErbB-1) Antibody for Passive Immunotherapy in Dog Cancer Patients. Molecular Cancer Therapeutics. 13(7). 1777–1790. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenhua Liang Breakdown of academic impact, for papers by Justin Stebbing Breakdown of academic impact, for papers by Lei Chen Breakdown of academic impact, for papers by Charles S. Dela Cruz Breakdown of academic impact, for papers by Peter C. Adamson Breakdown of academic impact, for papers by Mieke Van Hemelrijck Breakdown of academic impact, for papers by Paolo Bruzzi Breakdown of academic impact, for papers by Wei Zhang Breakdown of academic impact, for papers by Diego Serraino Breakdown of academic impact, for papers by Gang Xu
Rankless by CCL
2026